Effect of Vranaropana Taila in Episiotomy wound

A clinical study to evaluate the effect of Vranaropana Taila on wound healing and pain in management of episiotomy wound in comparison with Povidone Iodine. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/063472

Enrollment

100

Registered

2024-03-01

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O85-O92- Complications predominantly related to the puerperium

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: PRIMI PATIENTS WITH EPISIOTOMY

Exclusion criteria

Exclusion criteria: 1. Systemic Diseases like Diabetes Mellitus 2. Patients with perineal tears 3. Patients with cervical tears 4. Patients with pre-existing local e.g. wound,boil,etc. or systemic infection e.g. cough,etc.

Design outcomes

Primary

Measure	Time frame
Wound healing and pain management will be assessed for patients in both arms and it is expected that vranaropana taila will be more effective than povidone iodine in above mentioned actions. observations will be taken before and after treatment. Taila application and povidone iodine application will be done for 7 days twice daily morning and evening.Timepoint: First observation will be recorded on first day and second observation will be recorded on seventh day. i.e. baseline and on 7th day.	—

Measure

Time frame

Wound healing and pain management will be assessed for patients in both arms and it is expected that vranaropana taila will be more effective than povidone iodine in above mentioned actions. observations will be taken before and after treatment. Taila application and povidone iodine application will be done for 7 days twice daily morning and evening.Timepoint: First observation will be recorded on first day and second observation will be recorded on seventh day. i.e. baseline and on 7th day.

—

Secondary

Measure	Time frame
NATimepoint: NA	—

Countries

India

Contacts

Public ContactDR VIVEK JOG

PMTS AYURVED MAHAVIDYALAYA AND SHRI EKNATH RUGNALAYA

DR.DARUWALEJAFAR@REDIFFMAIL.COM9766481152

Outcome results